Immunoinformatics & Systems Immunology

Immunology exploration tends to a fascinating medium for the preface, understanding and explanation of complex sensible information. Data appears as illuminative mix plates, exceptional exploration papers, councils, medications and theoretical structures. The position of argument reaches to the cell immunology, excrescence immunology, immunoregulation, immunopathology, supplementary immunology, molecular immunology and autoimmunity have assured and microbial restriction including viral immunology, transplantation immunology, Immunoendocrinology, translational immunology, Neuroimmunology and clinical immunology.

  • Antibody Engineering & Technology
  • Proteomics
  • Antigen-Antibody Interactions
  • Microarray
  • Recombinant Immuno-Conjugates
  • Characterization of Lymphocytes
  • Immunodiagnostic & Immuno techniques
  • Transcriptomics              
  • Immunological Assay
  • Nano-Immunotechnology
  • Technology Development and Applications


Comments

Post a Comment

Popular posts from this blog

Immunodermatology studies skin

Image
Immunodermatology studies skin as an organ of impunity in health and conditions. Several areas like print-immunology (goods of UV light on skin defense), seditious conditions like Hidradenitis Suppurativa, antipathetic contact dermatitis and atopic eczema, presumably autoimmune conditions like vitiligo and psoriasis, and eventually the immunology of microbial skin conditions similar as retrovirus infection and leprosy.  Cutaneous Dendritic Cells in Health and Disease Photo immunology Atopic Dermatitis Non-melanoma Skin Cancer Immunobiology & Immune-Based Therapies Drug Eruptions Immunodermatology & Viral Skin Infection Clinical Dermatology Cutaneous T-Cell Lymphoma Allergic Urticaria Alopecia Areata Cutaneous Lupus Erythematosus Pemphigoid Spectrum Epidermolysis Bullosa Acquisita Immunoglobulin Dermatitis Advances in Immuno-Dermatology
Read more

Tumor-agnostic treatment treatments approved

Image
  Tumor-agnostic treatment is a drug treatment that is used to treat any kind of cancer, regardless of where in the body it started or the type of tissue from which it developed. This type of treatment can be used when the tumor has a very specific molecular alteration that is targeted by the drug or predicts that the drug is likely to work. Pembrolizumab was the first drug to be approved with a tumor-agnostic indication. Pembrolizumab is a type of immunotherapy, a drug that works by releasing the brakes on the immune system. In 2017, pembrolizumab was approved by the FDA to treat adults and children with solid tumors that have spread, called metastatic, or that cannot be treated with surgery, called unresectable. These tumors must also have a molecular alteration called microsatellite instability-high (MSI-H) or DNA mismatch repair deficiency (dMMR). Tumors that have MSI-H or dMMR have difficulty repairing damage to their DNA. As a result, they often develop large numbers of mutatio
Read more

Protective HLA Alleles Recruit Biased and for the most part Similar Antigen-Specific T cell Repertoires across completely different Outcomes in HIV Infection.

Image
CD8+ T cells play a very important role within the management of untreated HIV infection. many studies have advised a decisive role of TCRs concerned in anti-HIV immunity. HLA-B*27 and B*57 area unit typically related to a delayed HIV malady progression, however the precise correlates that offer superior immunity against HIV aren't legendary. to research if the T cell repertoire underlies the protecting impact in malady outcome in HLA-B*27 and B*57+ people, we tend to analyzed Ag-specific TCR profiles from progressors (n = 13) and slow progressors (n = 11) expressing either B*27 or B*57. Our knowledge showed no variations in TCR diversity between progressors and slow progressors. each alleles recruit biased T cell repertoires (i.e., TCR populations inclined toward specific TRBV families or CDR3 regions). This bias was unrelated to malady progression and was remarkably profound for HLA-B*57, within which TRBV family usage and CDR3 sequences were shared to some extent even between ep
Read more